Perenti Limited
Perenti Limited (PRN.AX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Perenti Limited (PRN.AX), covering cash flow, earnings, and balance sheets.
Perenti Limited (PRN.AX) Income Statement & Financial Overview
Analyze Perenti Limited’s PRN.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.71B | $1.63B | $1.44B | $1.44B |
| Cost of Revenue | $1.21B | $1.34B | $1.19B | $1.18B |
| Gross Profit | $501.50M | $289.99M | $250.31M | $254.13M |
| Gross Profit Ratio | $0.29 | $0.18 | $0.17 | $0.18 |
| R&D Expenses | $373000.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $30.67M | $174.24M | $143.07M | $147.80M |
| Operating Expenses | $31.04M | $178.27M | $146.26M | $157.52M |
| Total Costs & Expenses | $1.24B | $1.52B | $1.34B | $1.34B |
| Interest Income | $2.75M | $33.45M | $997000.00 | $770000.00 |
| Interest Expense | $46.86M | $0.00 | $31.22M | $33.39M |
| Depreciation & Amortization | $182.07M | $186.30M | $156.18M | $161.47M |
| EBITDA | $317.61M | $278.95M | $272.39M | $244.44M |
| EBITDA Ratio | $0.19 | $0.18 | $0.18 | $0.18 |
| Operating Income | $470.45M | $111.72M | $104.05M | $96.62M |
| Operating Income Ratio | $0.27 | $0.07 | $0.07 | $0.07 |
| Other Income/Expenses (Net) | -$403.71M | -$9.63M | -$19.06M | -$15.40M |
| Income Before Tax | $66.75M | $102.09M | $84.99M | $81.22M |
| Income Before Tax Ratio | $0.04 | $0.06 | $0.06 | $0.06 |
| Income Tax Expense | $29.39M | $32.28M | $26.44M | $37.18M |
| Net Income | $30.68M | $64.79M | $56.08M | $39.66M |
| Net Income Ratio | $0.02 | $0.04 | $0.04 | $0.03 |
| EPS | $0.03 | $0.08 | $0.08 | $0.06 |
| Diluted EPS | $0.03 | $0.08 | $0.08 | $0.06 |
| Weighted Avg Shares Outstanding | $932.76M | $809.89M | $685.70M | $695.81M |
| Weighted Avg Shares Outstanding (Diluted) | $973.96M | $841.44M | $720.89M | $708.23M |
The company's financials show resilient growth, with revenue advancing from $1.44B in Q2 2023 to $1.71B in Q4 2024. Gross profit remained healthy with margins at 29% in Q4 2024 compared to 18% in Q2 2023. Operating income hit $470.45M last quarter, sustaining a consistent 27% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $317.61M. Net income dropped to $30.68M, while earnings per share reached $0.03. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan